Lunai Bioworks Inc.
LNAI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001527728
No open-market purchases or sales by Lunai Bioworks Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $641.0K in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Lunai Bioworks Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −4 vs. Q1 2021
- Shares held
- 2.67M
- −43.9K (−1.6%) vs. Q1 2021
- Total value
- $13.3M
- +$3.67M (+38.2%) vs. Q1 2021
- New holders
- 10
- 2 more added
- Sold out
- 14
- 22 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LNAI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $641.0K |
| Q1 2026 | 29 | $403.3K |
| Q4 2025 | 24 | $981.7K |
| Q3 2025 | 20 | $1.38M |
| Q2 2025 | 45 | $4.17M |
| Q1 2025 | 63 | $12.0M |
| Q4 2024 | 58 | $18.5M |
| Q3 2024 | 50 | $7.13M |
| Q2 2024 | 39 | $24.8M |
| Q1 2024 | 41 | $19.2M |
| Q4 2023 | 36 | $8.16M |
| Q3 2023 | 21 | $6.65M |
| Q2 2023 | 32 | $1.13M |
| Q1 2023 | 40 | $3.02M |
| Q4 2022 | 39 | $3.74M |
| Q3 2022 | 43 | $6.87M |
| Q2 2022 | 51 | $7.64M |
| Q1 2022 | 43 | $21.5M |
| Q4 2021 | 44 | $18.0M |
| Q3 2021 | 34 | $10.2M |
| Q2 2021 | 37 | $13.3M |
| Q1 2021 | 41 | $9.60M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Lunai Bioworks Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| New York State Common Retirement Fund | 96 | $0 | 0.00% | −8,404−98.9% | Reduced |
| Wells Fargo & Company | 95 | $0 | 0.00% | −4,698−98.0% | Reduced |
| Citigroup Inc | 53 | $0 | 0.00% | −862−94.2% | Reduced |
| Ellis Investment Partners, LLC | 100 | $0 | 0.00% | −400−80.0% | Reduced |
| Cutler Group LP | 100 | $0 | 0.00% | +100 | New |
| TD Private Client Wealth LLC | 125 | $621 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 209 | $1.00K | 0.00% | −43,597−99.5% | Reduced |
| UBS Group AG | 260 | $1.00K | 0.00% | −3,291−92.7% | Reduced |
| Meeder Asset Management Inc | 574 | $3.00K | 0.00% | 00.0% | Unchanged |
| Skandinaviska Enskilda Banken AB (publ) | 2,250 | $11.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,702 | $13.0K | 0.00% | −28,413−91.3% | Reduced |
| BNP Paribas Arbitrage, SA | 3,285 | $16.3K | 0.00% | −2,272−40.9% | Reduced |
| Barclays PLC | 3,908 | $20.0K | 0.00% | −16,572−80.9% | Reduced |
| Royal Bank of Canada | 4,401 | $22.0K | 0.00% | +3,311+303.8% | Added |
| Jacobi Capital Management LLC | 4,500 | $22.0K | 0.00% | +4,500 | New |
| Bank of New York Mellon Corp | 11,377 | $57.0K | 0.00% | −40,638−78.1% | Reduced |
| Jane Street Group, LLC | 11,948 | $59.0K | 0.00% | +11,948 | New |
| ETF Managers Group, LLC | 14,099 | $72.0K | 0.00% | −220−1.5% | Reduced |
| Susquehanna International Group, LLP | 18,127 | $90.0K | 0.00% | +18,127 | New |
| Morgan Stanley | 18,987 | $93.0K | 0.00% | −146−0.8% | Reduced |
| Parametric Portfolio Associates LLC | 21,787 | $108.0K | 0.00% | +3,424+18.6% | Added |
| Northern Trust Corp | 28,103 | $140.0K | 0.00% | −122,676−81.4% | Reduced |
| State Street Corp | 32,791 | $163.0K | 0.00% | −155,381−82.6% | Reduced |
| First Trust Advisors LP | 37,618 | $187.0K | 0.00% | −1,317−3.4% | Reduced |
| HRT Financial LP | 41,058 | $204.0K | 0.00% | −41,578−50.3% | Reduced |
| Tibra Equities Europe Ltd | 41,900 | $208.0K | 0.06% | +41,900 | New |
| Goldman Sachs Group Inc | 42,468 | $211.0K | 0.00% | −12,954−23.4% | Reduced |
| United Capital Financial Advisers, LLC | 47,691 | $237.0K | 0.00% | −23,600−33.1% | Reduced |
| Ergoteles LLC | 47,984 | $238.0K | 0.01% | +47,984 | New |
| Truist Financial Corp | 59,660 | $297.0K | 0.00% | +59,660 | New |
| Virtu Financial LLC | 68,007 | $338.0K | 0.03% | +68,007 | New |
| Dimensional Fund Advisors LP | 80,825 | $402.0K | 0.00% | −4,096−4.8% | Reduced |
| Millennium Management LLC | 116,666 | $580.0K | 0.00% | +116,666 | New |
| BlackRock Inc. | 142,422 | $707.0K | 0.00% | −820,106−85.2% | Reduced |
| Geode Capital Management, LLC | 148,059 | $735.0K | 0.00% | −146,180−49.7% | Reduced |
| Vanguard Group Inc | 273,656 | $1.36M | 0.00% | −52,662−16.1% | Reduced |
| Sabby Management, LLC | 1,341,663 | $6.67M | 1.44% | +1,341,663 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −37,563−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −34,578−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −29,338−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −27,900−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −23,991−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −21,280−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −19,512−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −15,032−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −8,782−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −8,039−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,249−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,096−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −389−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −355−100.0% | Sold out |